Additionally, a positive correlation of Turicibacter with cytotoxic T cells and NK cell populations in the tumor microenvironment as well as serum levels of Eotaxin and IL-5 indicate a treatment-specific change in the gut microbiome (Figure 6A-C). This evidence concerns the gene IL5 and neoplasm.